Show simple item record

2021-09-19Zeitschriftenartikel
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters
dc.contributor.authorWilliamson, Brandi N.
dc.contributor.authorPrescott, Joseph
dc.contributor.authorGarrido, Jose L.
dc.contributor.authorAlvarez, Raymond A.
dc.contributor.authorFeldmann, Heinz
dc.contributor.authorBarría, Maria I.
dc.date.accessioned2024-07-25T16:35:41Z
dc.date.available2024-07-25T16:35:41Z
dc.date.issued2021-09-19none
dc.identifier.other10.3201/eid2710.210735
dc.identifier.urihttp://edoc.rki.de/176904/11855
dc.description.abstractAndes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available. We show that a combined treatment with 2 monoclonal antibodies protected Syrian hamsters when administered at midstage or late-stage disease.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleTherapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamstersnone
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/11855-2
dc.type.versionpublishedVersionnone
local.edoc.container-titleEmerging Infectious Diseasesnone
local.edoc.container-issn1080-6059none
local.edoc.pages4none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://wwwnc.cdc.gov/eid/none
local.edoc.container-publisher-nameCenters for Disease Control and Preventionnone
local.edoc.container-volume27none
local.edoc.container-issue10none
local.edoc.container-reportyear2021none
dc.description.versionPeer Reviewednone

Show simple item record